Skip to content
Home/Companies/Pharma/Sinder
Sinder

Sinder

Pharma·China·Exited 2014·Held 6yr
Entry
2008
Hold
6yr
Exit
2014

Who owns Sinder?

Sinder is a Chinese Pharma company, formerly owned by Cathay Capital, exited in 2014 (exit via Trade Sale). No current private equity owner is on file.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Cathay Capital
Investor
Cathay Capital
Cathay Capital Small Cap I · 2007 · Growth

Key facts

HQChina
SectorPharma
Websitewww.sinderanimalhealth.com
Exit Type
Trade Sale
Exit Year
2014

More from Cathay Capital Small Cap I

Other portfolio companies in the same fund.

DESSANGE
Dessange
Exited 2015
ConsumerFrance· 2009
DOTSOFT
Dotsoft
Exited 2015
SoftwareFrance· 2009
EUROGERM
Eurogerm
Exited 2017
IndustrialsFrance· 2009
to Novagerm
Sogal
Exited 2016
ConsumerFrance· 2009
to Qualium Investissement
Suofeiya
Exited 2012
ConsumerChina· 2009
to SOGAL FRANCE
C.C.D. International
Exited 2014
HealthcareFrance· 2008

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS

Questions

Who owns Sinder?

Sinder was formerly owned by Cathay Capital, exited in 2014. No current private equity owner is on file.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue